Ax­el Hoos, the keep­er of the on­col­o­gy flame at Glax­o­SmithK­line, steps away for his next chal­lenge at tiny Scor­pi­on

Ax­el Hoos has long kept the flame alive at Glax­o­SmithK­line’s on­col­o­gy di­vi­sion, en­dur­ing lean days af­ter the British phar­ma ditched its late-stage pipeline to No­var­tis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER